Ripple Regains SEC Approval to Raise Private Capital After Five-Year Restriction

Ripple can now raise private capital again after the SEC removed its bad actor designation under Rule 506(d).

Several public companies have increased XRP holdings showing rising corporate interest in the digital asset.

The SEC waiver gives Ripple faster access to funding and supports its long term strategic growth goals.

Ripple has regained the right to raise private capital after the U.S. Securities and Exchange Commission granted a key waiver. The decision removes the company’s “bad actor” label, which had blocked certain fundraising exemptions for five years

These exemptions, under Regulation D, allow firms to raise unlimited funds from accredited investors without full SEC registration. The change offers Ripple faster and less costly access to capital.

Impact of Previous Restriction

The restriction stemmed from Rule 506(d), which disqualifies companies found to have violated securities laws. This designation followed a prior court ruling that left Ripple with only complex and expensive fundraising options

The SEC’s waiver now clears that barrier, enabling Ripple to conduct exempt securities offerings again. This restored pathway is a vital tool for startups and growth-stage firms seeking strategic growth capital.

Conditions and Regulatory Shift

The SEC granted the relief under specific conditions. The move signals a willingness to assess cryptocurrency-related cases individually. Industry observers believe this could shape how similar enforcement disputes are handled in the future. The timing aligns with increasing interest from publicly listed companies in holding XRP as part of their corporate treasuries.

Growing Corporate XRP Holdings

Several companies have recently disclosed XRP purchases alongside other major cryptocurrencies. Quantum Biopharma Ltd added XRP and Ethereum to its portfolio, complementing its holdings in Bitcoin, Dogecoin, and Solana. Worksport Ltd increased its Bitcoin position and also holds XRP, with board approval for further crypto purchases capped at a set percentage of excess cash

Flora Growth Corp and Hyperscale Data Inc. revealed their XRP allocations, with Hyperscale’s subsidiary Ault Capital Group planning a $10 million investment for cross-border settlement

VivoPower raised $121 million to fund its projects and became the first publicly traded company to form a specialized XRP treasury. The firm also linked its XRP plans to potential inclusion in a proposed U.S. Strategic Digital Asset Reserve.

Strategic Advantages for Ripple

The restored access to Regulation D funding strengthens Ripple’s financial position. It provides agility to reach accredited investors ahead of any possible public listing. The change also reduces legal expenses and shortens fundraising timelines

This new flexibility supports Ripple’s broader objectives, which include pursuing a national bank charter. The company now holds a stronger position to execute its growth strategy in both domestic and global markets.